Status and phase
Conditions
Treatments
About
The goal of this clinical trial is to understand the safety of AXT107 injected suprachoroidally in participants with nAMD. The main question[s] it aims to answer are:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
15 participants in 3 patient groups
Loading...
Central trial contact
Amanda Boillino, RN
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal